investorscraft@gmail.com

Intrinsic value of Healthpeak Properties, Inc. (PEAK)

Previous Close$26.51
Intrinsic Value
Upside potential
Previous Close
$26.51
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.
Use floor (the cash flow based valuation has rendered a result, which is lower than an estimated minimum value derived from the company’s balance sheet analysis)

VALUATION INPUT DATA (original, your and others' valuations)

ParameterOrig.Your
Date of valuation (DoV)  
Intrinsic value (IV) at DoV, $/sh  
IV at current val. algorithm, $/sh10.75 

The original valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-03-31.

Registered users can save their valuation input data

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

NOTE: The bar chart shows historic and forecasted yearly revenue growth rates. Its purpose is to help you in determining what initial revenue rate you want to base your stock valuation on. Please make sure that you are confident in the value you select - for most stocks it is by far the most important parameter in valuation.

Company description

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles. At Healthpeak, we pair our deep understanding of the healthcare real estate market with a strong vision for long-term growth.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2021(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %15.3NaN
Revenue, $1896NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m1581NaN
Operating income, $m315NaN
EBITDA, $m933NaN
Interest expense (income), $mNaN
Earnings before tax, $m502NaN
Tax expense, $m-3NaN
Net income, $m505NaN

BALANCE SHEET

Cash and short-term investments, $m212NaN
Total assets, $m15258NaN
Adjusted assets (=assets-cash), $m15046NaN
Average production assets, $m751NaN
Working capital, $m-79NaN
Total debt, $m6552NaN
Total liabilities, $m8743NaN
Total equity, $m6515NaN
Debt-to-equity ratio1.006NaN
Adjusted equity ratio0.419NaN

CASH FLOW

Net income, $m505NaN
Depreciation, amort., depletion, $m617NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m833NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m306NaN
Free cash flow, $m527NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m-79
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount